Regarding the underlying molecular mechanisms of RA-ILD, the activation of biological processes (FMT, EMT, and immunological pathways) and signaling pathways (JAK/STAT and PI3K/Akt) could be deleterious and may contribute to the development of RA-ILD. The gene discussed is AKT1; the disease is interstitial lung disease.